Canrenoic acid
| Canrenoic acid | |
|---|---|
| Canrenoic_acid.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Canrenoic acid is a pharmaceutical drug that acts as a potassium-sparing diuretic. It is primarily used in the treatment of conditions such as congestive heart failure, hypertension, and edema.
Pharmacology[edit]
Canrenoic acid is a prodrug of canrenone, which is an active metabolite. It works by antagonizing the effects of aldosterone, a hormone that promotes the retention of sodium and water in the body. By inhibiting aldosterone, canrenoic acid helps to increase the excretion of sodium and water while retaining potassium, thus acting as a diuretic.
Mechanism of Action[edit]
Canrenoic acid binds to the mineralocorticoid receptor in the kidney, preventing aldosterone from exerting its effects. This leads to increased excretion of sodium and water, while potassium is retained, which is beneficial in conditions where potassium loss is a concern.
Clinical Uses[edit]
Canrenoic acid is used in the management of:
- Congestive heart failure
- Hypertension
- Edema associated with liver cirrhosis or nephrotic syndrome
Side Effects[edit]
Common side effects of canrenoic acid include:
- Hyperkalemia (elevated potassium levels)
- Hyponatremia (low sodium levels)
- Gastrointestinal disturbances
Contraindications[edit]
Canrenoic acid should not be used in patients with:
